Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Influenza (trivalent) vaccine by Novavax for Seasonal Influenza: Likelihood of Approval
Influenza (trivalent) vaccine is under clinical development by Novavax and currently in Phase II for Seasonal Influenza. According to GlobalData,...